about
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk NeuroblastomaAlgorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission.mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling.USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.Giant invasive spinal schwannoma in children: a case report and review of the literatureFocal nodular hyperplasia in children: an institutional experience with review of the literature.Bronchial Mucoepidermoid Carcinoma With the Classic MAML2 Gene Rearrangement in a 2-year-old Boy.TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.A 10-Month-Old Infant Presenting With Signs of Precocious Puberty Secondary to a Sclerosing Stromal Tumor of the Ovary in the Absence of Hormonal ElevationActivated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary NeuroblastomaThe Clinical Management and Outcomes of Pelvic Neuroblastic TumorsNon-Operative Management is More Cost-Effective than Immediate Operation in Perforated Appendicitis Patients with Seven or More Days of Symptoms
P50
Q28553602-F1BA3685-0B68-455A-8F6A-24AE89F4CDEFQ30856931-EF1192CA-0786-4521-BBBC-83133B084F62Q36121394-999ED739-AB5F-4919-8443-F88EAEC49D24Q37577477-8F7F7FEA-E196-47E1-8264-FF2594B2BBBDQ37620709-7EFD27D8-1716-4E1E-8B34-29E60AF2299AQ38174683-4BB686EF-AB57-45E4-BF94-A5D2C5C89C13Q38369173-DA521A0B-DB4D-4AE6-80A1-B4C20B9388EDQ40057515-346FDF50-5A5B-45A1-A4AB-780B8318571CQ46462751-B1B095F0-3226-49F9-992E-BB25DFECCE90Q48689521-C730BB58-87AC-45D3-8824-AB677586E44EQ90707466-9B572668-5F2B-4C0D-83BD-ED84721EFD25Q91554121-6341BCA0-B538-4F39-BB12-524B6BAFDDCAQ92521183-F16CE545-EF34-4E32-A065-2A64B60BE5E4Q92602558-6392554F-4775-4755-A95D-8CB5B9608021
P50
description
researcher (ORCID 0000-0001-7959-5614)
@en
name
Eugene S Kim
@en
type
label
Eugene S Kim
@en
prefLabel
Eugene S Kim
@en
P31
P496
0000-0001-7959-5614